Toceranib
Автор:
Jesse Russell,Ronald Cohn, 96 стр., издатель:
"Книга по Требованию", ISBN:
978-5-5116-4655-8
High Quality Content by WIKIPEDIA articles! Toceranib is a receptor tyrosine kinase inhibitor and is used in the treatment of canine mast cell tumor also called mastocytoma. Together with masitinib (Kinavet (US)/Masivet (EU/ROW) company: AB Science), Toceranib is the only dog-specific anti-cancer drug approved by the U.S. Food and Drug Administration. It is marketed as Palladia as its phosphate salt, toceranib phosphate (INN) by Pfizer. It was developed by SUGEN as SU11654 , a sister compound to SU11248, which was later approved for human therapies as Sutent. Toceranib is likely to act mostly through inhibition of the kit tyrosine kinase, though it may also have an anti-angiogenic effect. Данное издание представляет собой компиляцию сведений, находящихся в свободном доступе в среде Интернет в целом, и в информационном сетевом ресурсе "Википедия" в частности. Собранная по частотным запросам указанной тематики, данная компиляция построена по принципу подбора близких информационных...
Рейтинг книги:



4 из 5,
7 голос(-ов).